ERYTECH Pharma announces the oral presentation of positive Phase II clinical trial results in Acute Lymphoblastic Leukemia. Post author:admERY Post published:June 17, 2012 Post category:Newsroom You Might Also Like ERYTECH Provides Business Update and Reports Financial Results for the First Quarter of 2021 May 4, 2021 ERYTECH announces fast take-off of its Phase IIb study in Acute Myeloid Leukemia July 4, 2013 ERYTECH Pharma Voting Results by Resolution from Annual General Meeting Held on June 21, 2019 July 4, 2019
ERYTECH Provides Business Update and Reports Financial Results for the First Quarter of 2021 May 4, 2021
ERYTECH Pharma Voting Results by Resolution from Annual General Meeting Held on June 21, 2019 July 4, 2019
